🔎 Trials Near Me

Home › Blood Cancers › Wisconsin › Madison

Blood Cancers clinical trials in Madison, WI

7 studies for Blood Cancers are looking for participants at sites in and around Madison (within about 30 miles). Open a study to see who can join and how to contact the study team.

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Recruiting
  • UW Carbone Cancer Center, Madison
Ages 18 to 80 · All sexes · Updated Sep 14, 2026 · NCT07285668

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
  • University of Wisconsin, Madison
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • University of Wisconsin - Madison, Madison
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

RecruitingPhase 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667

UWCCC Molecular Tumor Board Registry

RecruitingObservational study
  • University of Wisconsin Carbone Cancer Center, Madison
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03023202

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • University of Wisconsin Hospital and Clinics, Madison
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

Blood Cancers trials in other cities

Other studies in Madison

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.